On August 26, 2020 Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, reported that Mr. Darren Lui, President and Executive Director of Aptorum Group, and Dr. Herman Weiss, CEO and Executive Director of Claves Life Sciences Limited and Senior Medical Advisor of Aptorum Group, will present at the LD 500 investor conference and H.C. Wainwright 22nd Annual Global Life Sciences Conference in September (Press release, Aptorum, AUG 26, 2020, View Source [SID1234564059]). To RSVP for the virtual conferences, please click through: View Source and View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The LD 500 Virtual Conference

Date: Tuesday, September 1, 2020
Time: 9:20 AM Eastern Time (6:20 AM Pacific Time)

To book 1-on-1 investor meetings with Aptorum Group, please register for the virtual event here: https://ld-micro-conference.events.issuerdirect.com/signup

If you can’t attend the live presentation, the Company’s presentation webcast will be available on the conference event platform under the "Schedule" tab at https://ld-micro-conference.events.issuerdirect.com/presenting-companies

H.C. Wainwright 22nd Annual Global Life Sciences Conference

Date: Tuesday, September 15, 2020
Time: 9:30 AM Eastern Time (6:30 AM Pacific Time)

To book 1-on-1 investor meetings with Aptorum Group, please register for the virtual event here: View Source